The legacy success of sildenafil has undeniably shaped the drug landscape. However, investing in companies heavily focused on generic versions and the declining patent protection surrounding this iconic https://rotatesites.com/story22913407/the-blue-pill-and-pharmaceutical-companies-a-risky-venture